Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedEnrollment status now shows 'No longer looking for participants,' indicating that recruitment for this study has ended. The page also adds new help/navigation items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updates the revision label to v3.6.0, while removing the older 'Intervention / Treatment' header variant.SummaryDifference0.4%

- Check21 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, signaling a minor version update rather than changes to the study details.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page footer shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a small update to the page's versioning/documentation rather than a change to the study content.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.0 to v3.5.3, indicating a minor platform/site release without altering the underlying study details.SummaryDifference0.1%

- Check100 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No visible changes to the study details page were observed.SummaryDifference0.1%

- Check114 days agoChange DetectedRevision label updated to v3.4.3 (replacing the previous v3.4.2).SummaryDifference0.1%

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.